Article
Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis.
Pharmacogenomics - 1 Jan 2018
Naidoo Anushka, Ramsuran Veron, Chirehwa Maxwell, Denti Paolo, McIlleron Helen, Naidoo Kogieleum, Yende-Zuma Nonhlanhla, Singh Ravesh, Ngcapu Sinaye, Chaudhry Mamoonah, Pepper Michael S, Padayatchi Nesri
Abstract excerpt
AIM: We assessed the effect of genetic variability in UGT1A and ABCB1 genes on moxifloxacin pharmacokinetics. METHODS: Genotypes for selected UGT1A and ABCB1 SNPs were determined using a TaqMan® Genotyping OpenArray™ and high-resolution melt analysis for rs8175347. A nonlinear mixed-effects model was used to describe moxifloxacin pharmacokinetics. RESULTS: Genotypes of UGT1A SNPs, rs8175347 and rs3755319 (20.6%...
Read the complete abstract on PubMed